Analysts at Bank of America upgraded Cepheid CPHD from Neutral to Buy.
The price target for Cepheid has been raised from $56 to $60.
Cepheid shares have jumped 6.69% over the past 52 weeks, while the S&P 500 index has gained 11.23% in the same period.
Cepheid's shares rose 4.71% to close at $49.79 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
